. Author manuscript; available in PMC: 2014 Oct 16.

Published in final edited form as: Gynecol Oncol. 2012 Nov 28;128(3):552–559. doi: 10.1016/j.ygyno.2012.11.024

Table 2. Multivariate analysis for disease-free survival outcome in endometrial cancer.

	HR (95% CI)	P-value
FIGO stage	9.192 (3.540, 23.869)	<.0001
FIGO grade	1.847 (0.873, 3.907)	0.11
Visceral adipocyte GRP78	1.491 (1.017, 2.185)	0.041

Multivariate Cox proportional hazards regression model. Hazard ratio represents stage (III-IV vs. I-II), grade (3 vs. 1-2), and visceral adipocyte GRP78 (quartiles from 1 to 4), respectively. Abbreviations: HR, hazard ratio; 95% CI, 95% confidence interval; FIGO, the International Federation of Gynecology and Obstetrics stage; and GRP78, glucose-regulated protein 78.